Citations 0
Health Agencies Update
July 28, 2004

Type 1 Diabetes Trials

JAMA. 2004;292(4):426. doi:10.1001/jama.292.4.426-d

A newly formed network of 18 clinical centers in the United States, Canada, Europe, and Australia is launching clinical studies on type 1 diabetes. The network, Type I Diabetes TrialNet, has initiated two trials, one to understand the biological basis of type 1 diabetes and the other to preserve insulin-secreting β cells in patients newly diagnosed with the disease.

Researchers have been studying the genetic and immune markers for type 1 diabetes for years, and now they hope these efforts will be used to help prevent the disease or stop it from progressing after diagnosis.

First Page Preview View Large
First page PDF preview
First page PDF preview